CD8A and COVID-19: After stimulation with αCD3 and αCD28, similar proportions of CD8 T cells from COVID-19 patients and HD controls produced IFNγ, which suggests that PBMCs from COVID-19 patients were responsive to T cell receptor cross-linking (fig.